Balanced Fluids vs. Saline in Pediatric Septic Shock: Novel Evidence Guides Treatment
When children arrive at hospitals with septic shock, every decision about fluid resuscitation can influence survival. For decades, clinicians have debated whether balanced crystalloids—solutions designed to more closely mimic human plasma—offer advantages over the traditional 0.9% saline. Recent research published in the New England Journal of Medicine provides new clarity on this critical question, offering evidence that could reshape emergency care for seriously ill children worldwide.
The multicenter randomized trial, conducted across pediatric intensive care units in Australia and New Zealand, directly compared balanced fluids (specifically Plasma-Lyte 148) with 0.9% saline in children requiring fluid resuscitation for septic shock. The study enrolled 1,460 participants aged from 28 days to 18 years, making it one of the largest investigations to date on fluid choice in pediatric sepsis. Researchers tracked multiple outcomes, including mortality, organ support requirements, and markers of kidney injury, to determine whether one solution conferred a meaningful clinical advantage.
According to the findings, there was no statistically significant difference in 90-day mortality between the two groups. Approximately 12.4% of children receiving balanced fluids died within 90 days, compared to 13.1% in the saline group—a difference that fell within the range of chance variation. Similarly, rates of new kidney injury, necessitate for mechanical ventilation, and duration of hospital or intensive care stay showed no meaningful divergence between the treatment arms. These results suggest that, for overall survival and major organ support, the choice between these two common intravenous fluids may not significantly alter outcomes in pediatric septic shock.
However, the study did reveal a nuanced signal worth noting. Children who received balanced fluids experienced a slightly faster resolution of hyperlactatemia—a marker of tissue stress and impaired perfusion—than those given saline. While this finding did not translate into a clear benefit in hard endpoints like survival or organ failure, it hints at potential physiological differences in how the two solutions affect early recovery from shock. Researchers cautioned that this observation requires further investigation before influencing clinical practice, as it could reflect chance or be mediated by unmeasured variables.
The trial’s design strengthened its validity through rigorous methodology. Enrollment occurred over four years across 27 hospitals, with randomization stratified by site and severity of illness. Clinicians and outcome assessors remained blinded to fluid assignment, reducing bias in subjective evaluations. The use of Plasma-Lyte 148—a balanced crystalloid containing acetate, gluconate, and magnesium in addition to sodium and chloride—allowed a direct comparison against saline’s simpler composition of sodium and chloride in water. This contrast enabled researchers to isolate the effects of chloride load and strong ion difference, theoretical factors that have long fueled debate about saline’s potential to cause hyperchloremic acidosis.
Despite the absence of a mortality benefit, experts emphasize that the findings do not diminish the importance of timely, adequate fluid resuscitation in septic shock. Guidelines from organizations such as the Surviving Sepsis Campaign continue to recommend rapid administration of crystalloids as first-line therapy, with careful monitoring for signs of fluid overload. The choice between balanced solutions and saline may ultimately depend on institutional protocols, cost considerations, and individual patient factors—such as pre-existing kidney disease or electrolyte imbalances—where theoretical advantages of balanced fluids might become more relevant.
Ongoing research continues to explore whether specific subgroups of children—such as those with severe acidosis, renal impairment, or requiring large volumes of fluid—might derive greater benefit from balanced crystalloids. A secondary analysis from the same trial is currently under review, focusing on patients with baseline kidney dysfunction. A large-scale pragmatic trial in North America, known as the SALT-ED Pediatric study, is expected to report results later in 2026, which could further inform the balance between efficacy, safety, and practicality in fluid selection.
For clinicians at the bedside, the takeaway remains clear: prompt recognition and treatment of septic shock save lives, and both balanced fluids and saline are acceptable options for initial resuscitation. While the search for optimal intravenous fluids continues, the priority remains delivering timely, goal-directed care tailored to each child’s physiological needs. Families and caregivers should feel reassured that current standards of care are grounded in rigorous evidence, even as science refines our understanding of the tools we use.
The next update on this research is expected with the publication of the SALT-ED Pediatric trial results, anticipated for late 2026. Until then, clinicians are encouraged to follow local guidelines and participate in institutional quality improvement programs that monitor resuscitation practices and outcomes.
We welcome your thoughts and experiences. Have you observed differences in clinical response when using balanced fluids versus saline in pediatric cases? Share your insights in the comments below to help foster a global conversation on improving care for critically ill children.